Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine A for Epiphora in Acquired Punctal Stenosis
NCT04637633Phase 3Completed
- Sponsor
- Farwaniya Hospital
- Start
- Aug 2020
- Primary completion
- Oct 2020
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of CyclAGel in epiphora, sponsored by Farwaniya Hospital. Primary endpoint: Epiphora grading at 3 months. Started Aug 2020; status: completed.
02
Drugs
CyclAGel
03
Conditions
epiphora
Beyond the preview
Go deeper on NCT04637633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04637633.